Phase Holographic Imaging (PHI) closes its fiscal year with nearly 60 per cent revenue growth, a strengthened balance sheet and preparations in full swing for the launch of its next-generation live cell imaging system, HoloMonitor. With new leadership appointments and expanded global distribution, the company is positioning itself for entry into clinical markets such as regenerative medicine, oncology and IVF.
Read more at biostock.se:
Strong year paves the way for PHI's next major launch
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/